ucsf.edu Objective Selective serotonin reuptake inhibitor ... each individual component of the primary outcome and more severe neonatal outcomes (pulmonary hypertension, hypoxic-ischaemic ...

Pulmonary arterial hypertension is caused by narrowing of the blood vessels in the lungs. Learn how it happens, including ...

Investigators used 4D flow cardiovascular magnetic resonance imaging to search for differences between pulmonary artery (PA) ...

Pulmonary arterial hypertension (PAH) can be a challenging complication to manage during pregnancy; women with PAH who are ...

A new program in the Central Valley is now offering much-needed treatments for patients suffering from an advanced form of lung disease called pulmonary ...

NTM lung disease predominantly affects individuals with compromised immune systems or preexisting lung conditions, such as bronchiectasis and chronic obstructive pulmonary disease (COPD). UCSF’s ...

Thousands of people at UCSF work with the purpose of offering hope for the future of every child. Gabby, HT and Brooklyn are ...

Pulmonary embolism is a common cause of cardiovascular-associated morbidity and mortality. Although pulmonary embolism ...

A group of 29 international experts says that simultaneous screening for hypertension and heart arrhythmia could prevent ...

Highlight box Key findings • The bibliometric analysis summarized the major areas and promising research directions on chronic thromboembolic pulmonary hypertension (CTEPH) over the past two decades.

Learn about the increased pressure in the portal vein, its causes like cirrhosis, and resulting complications such as ...